The use of psychotropic medication in people with learning disability: Towards rational prescribing
Authors:
- 1 July 1994
- journal article
- research article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
- Vol. 9 (4) , 259-272
Abstract
Between 20 per cent to 50 per cent of institutionalized people with a learning disability receive psychotropic medication. A similar or a slightly lower proportion of those who live in the community also receive these drugs. There is a decreasing rate of use of these drugs with the increasing age. The rate of psychotropic drug use seems to have declined in the last decade among the community‐based population. The two main reasons for the use of these drugs are psychiatric illness and behaviour disorder. These drugs cause unacceptable side‐effects in a proportion of patients. Recent double‐blind studies lend some support to the efficacy of zuclopenthixol in the treatment of behaviour disorder. Some drugs have been use on an experimental basis to treat behavioural problems with equivocal results. These include lithium carbonate, carbamazepine, sodium valproate, fluoxetine, buspirone, naloxone, naltrxone, dextroamphetamine, methylphenidate, fenfluramine, propranolol, nadolol, amantadine and midazolam. Non‐durg dietary regimes, such as folic acid, vitamin B6, magnesium, and specific amino‐acid rich diets have also been applied in the treatment of behavioural problems. Guidelines have been proposed for a common‐sense rational approach to the use of psychotropic drugs in people with a learning disability.Keywords
This publication has 79 references indexed in Scilit:
- The Safety and Efficacy of Clozapine in Severe Treatment-Resistant Schizophrenic Patients in the UKThe British Journal of Psychiatry, 1993
- Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic populationActa Psychiatrica Scandinavica, 1991
- A controlled case study of methylphenidate and fenfluramine in a young mentally retarded, hyperactive childAustralia and New Zealand Journal of Developmental Disabilities, 1990
- Guidelines for the use of psychotropic medication in individuals with developmental disabilitiesAustralia and New Zealand Journal of Developmental Disabilities, 1990
- Failure of Naloxone to reduce self-injurious behavior in two developmentally disabled femalesApplied Research in Mental Retardation, 1986
- Clopenthixol Decanoate in the Management of Aggressive Mentally Handicapped PatientsThe British Journal of Psychiatry, 1986
- Patterns of neuroleptic use among the institutionalised elderlyActa Psychiatrica Scandinavica, 1983
- Naloxone attenuates self-abusive behavior in developmentally disabled clientsApplied Research in Mental Retardation, 1983
- Adverse behavioral reactions in children treated with carbamazepine (Tegretol)The Journal of Pediatrics, 1982
- Hyperserotonemia and Early Infantile AutismNew England Journal of Medicine, 1982